KippsDeSanto & Co. advises Tri-Tech Forensics, Inc., a portfolio company of Point Lookout Capital Partners, on its purchase of SAM Medical

/in /by

KippsDeSanto & Co. is pleased to announce that its client, Tri-Tech Forensics, Inc. (“Tri-Tech”), a leading provider of tactical emergency medical solutions and human identification kits and a portfolio company of Point Lookout Capital Partners, has acquired SAM Medical Products, Inc. (“SAM” or “the Company”).

Founded in 1985 by Dr. Sam and Cherrie Scheinberg, SAM is an internationally recognized developer and manufacturer of emergency medical equipment and supplies based in Tualatin, Oregon. The Company has developed a variety of proprietary products, technologies, and intellectual property that provide high-quality, reliable and effective emergency medical solutions that elegantly solve the most problematic complications encountered by military medics and civilian first responders.

Tri-Tech designs and manufactures custom medical kits, patient transport systems, immobilization and airway management products. The Company is also the nation’s most proficient developer and manufacturer of human identification solutions, including its premier DNA collection kits. Tri-Tech was founded in 1983 and is headquartered in Leland, North Carolina.

“We are confident that joining the Tri-Tech family of companies will provide a bright future for SAM Medical,” Dr. Sam Scheinberg said. “Tri-Tech’s commitment to excellence and dedication to supporting those on the front lines of emergency care align perfectly with our values. I believe that the team Cherrie and I have built over the years will continue to thrive and make a meaningful impact in the field of emergency medicine under their stewardship.”

“Dr. Scheinberg’s pioneering spirit and his team’s focus on products to enhance patient outcomes has been vital in advancing the field of emergency care,” said Mr. Jim Seidel, CEO of Tri-Tech. “We have enjoyed partnering successfully with SAM Medical over the years and honored for them to become an integral part of the Tri-Tech family. We are committed in supporting SAM Medical in its continued innovation, growth and success.”

Read more in the full press release.

About KippsDeSanto & Co.

KippsDeSanto & Co. is an investment banking firm focused on serving growth-oriented Aerospace / Defense, Government Services and Technology companies. We are focused on delivering exceptional M&A and Financing transaction results to our clients via leveraging our scale, creativity, and industry experience. We help market leaders realize their full strategic value. Having advised on over 200 industry transactions since 2008, KippsDeSanto is recognized for our analytical rigor, market insight, and broad industry relationships. There’s no substitute for experience. For more information, visit www.kippsdesanto.com.

Investment Banking products and services are offered through KippsDeSanto & Co., a non-bank subsidiary of Capital One, N.A., a wholly-owned subsidiary of Capital One Financial Corporation, and a member of FINRA and SIPC. Products and services are Not FDIC Insured, Not Bank Guaranteed, May Lose Value, Not a Deposit, and Not Insured by Any Federal Government Agency.